The Emcure Pharma IPO to open for subscription tomorrow, July 3, 2024, and will close on July 5, 2024.
Namita Thapar, a Shark Tank India investor and member of the Emcure Pharmaceuticals promoter group, is expected to sell part of her holdings in the IPO, estimated to be worth ₹127 crore. Here’s a summary of the key details:
Emcure Pharma IPO Details:
- Issue Size: ₹1,952.03 crore
- Price Band: ₹960 to ₹1008 per share
- Lot Size: Minimum of 14 shares
- Listing: BSE and NSE
Grey Market Premium (GMP): The Emcure Pharma IPO GMP is +290, indicating that the shares are trading at a premium of ₹290 in the grey market. This suggests a potential listing price of ₹1,298 per share, a 28.77% premium over the upper end of the IPO price band.
Emcure Pharmaceuticals Limited is a leading Indian multinational pharmaceutical company, headquartered in Pune. Emcure Pharmaceuticals markets its diverse product portfolio in over 70 countries, with Europe and Canada as its primary international markets. The company operates 13 manufacturing facilities in India.
The IPO is a combination of a fresh issue of shares and an offer for sale (OFS). Namita Thapar, a Shark Tank India investor and member of the Emcure Pharmaceuticals promoter group, sold part of her holdings in the IPO.